Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

Men with more CAG repeats in the androgen receptor gene and lower testosterone levels may experience more severe COVID-19.

COVID-19 can cause various skin issues in children, mostly not severe, with chilblain-like lesions being common, especially in adolescents.

COVID-19 treatments and vaccines face challenges due to genetic differences in people and the virus.

Some early COVID-19 mutations in patients predicted future common virus mutations.

High-dose vitamin D3 does not improve symptoms or quality of life in COVID-19 patients after one year.

COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.

COVID-19 can cause long-lasting non-respiratory symptoms, especially in women.

COVID-19 pandemic increased alopecia areata cases and hospitalizations.

Hepatitis B vaccination can trigger HSP, and vitamin D correction and tonsillectomy can effectively manage it.

A COVID-19 infected patient with chronic kidney disease experienced worsened kidney function, hair loss, and unexpected wart clearance.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

Standardized definitions and better methods are needed to accurately estimate long COVID-19 prevalence.

70.7% of patients had long-COVID symptoms like fatigue, cough, and brain fog three months after recovery.

People in high-income countries are more likely to accept COVID-19 booster doses than those in middle or low-income countries.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

Females are more likely than males to experience long-COVID symptoms and heart issues.

The Covishield COVID-19 vaccine caused skin-related side effects in 1.23% of the people vaccinated in the study from India.

Most severe COVID-19 patients in Mexico experienced long-lasting symptoms that worsened their quality of life.

Teledermatology was popular among young adults and women, and high-resolution photos improved service during the pandemic.

Most COVID-19 survivors developed post-acute symptoms, especially if they had been in the ICU, but the severity of initial infection didn't predict these symptoms.

Older people with severe COVID-19, especially those with certain health conditions, are more likely to experience post-COVID syndrome.

The COVID-19 pandemic led to fewer patient visits, more visits by older adults, an increase in cutaneous T-cell lymphoma cases, and a rise in noncosmetic procedures at a dermatology clinic.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Booster doses of Covaxin improve protection against the Omicron variant.

Many hospitalized COVID-19 patients still have symptoms like fatigue and hair loss up to a year later, especially older, lower-income individuals with other health issues.